Stevanato Group S.p.A. $STVN Stock Holdings Lessened by First Eagle Investment Management LLC

First Eagle Investment Management LLC lowered its holdings in Stevanato Group S.p.A. (NYSE:STVN – Free Report) by 39.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 736,956 shares of the company’s stock after selling 485,616 shares during the quarter. First Eagle Investment Management LLC’s holdings in Stevanato Group were worth $15,461,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Wellington Management Group LLP bought a new stake in Stevanato Group in the second quarter valued at $22,621,000. Ranger Investment Management L.P. bought a new position in Stevanato Group in the 2nd quarter worth $21,438,000. Schwartz Investment Counsel Inc. raised its holdings in Stevanato Group by 15.0% in the 3rd quarter. Schwartz Investment Counsel Inc. now owns 661,136 shares of the company’s stock worth $13,871,000 after purchasing an additional 86,385 shares in the last quarter. Riverbridge Partners LLC lifted its position in shares of Stevanato Group by 4.2% in the 3rd quarter. Riverbridge Partners LLC now owns 625,914 shares of the company’s stock worth $13,132,000 after purchasing an additional 25,400 shares during the period. Finally, Fenimore Asset Management Inc purchased a new stake in shares of Stevanato Group in the 3rd quarter worth about $12,212,000.

Insider Buying and Selling

In related news, Director E Jr acquired 25,000 shares of Stevanato Group stock in a transaction dated Friday, November 6th. The shares were purchased at an average price of €13.07 per share, for a total transaction of €326,750.00. Following the completion of the transaction, the director directly owned 62,424 shares in the company, valued at approximately €815,881.68. This represents a 66.80% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William Federici purchased 20,000 shares of the firm’s stock in a transaction on Monday, November 9th. The stock was bought at an average price of €13.72 per share, for a total transaction of €274,400.00. Following the purchase, the director owned 46,991 shares in the company, valued at approximately €644,716.52. This represents a 74.10% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on STVN shares. Citigroup reduced their price target on shares of Stevanato Group from $26.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, November 4th. William Blair lowered shares of Stevanato Group from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 4th. Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. UBS Group reduced their target price on Stevanato Group from $23.00 to $16.00 and set a “neutral” rating on the stock in a report on Wednesday, November 4th. Finally, Deutsche Bank assumed coverage on Stevanato Group in a research report on Wednesday, October 7th. They issued a “hold” rating for the company. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.

View Our Latest Analysis on Stevanato Group

Stevanato Group Price Performance

NYSE STVN opened at €15.38 on Thursday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.19 and a current ratio of 1.73. The stock has a 50-day moving average of €18.84 and a 200 day moving average of €17.91. Stevanato Group S.p.A. has a one year low of €12.05 and a one year high of €24.01. The company has a market capitalization of $4.66 billion, a price-to-earnings ratio of 26.51, a PEG ratio of 1.57 and a beta of 0.80.

Stevanato Group (NYSE:STVN – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing the consensus estimate of €0.17 by (€0.01). Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. The business had revenue of €326.06 million for the quarter. On average, sell-side analysts forecast that Stevanato Group S.p.A. will post 0.67 EPS for the current year.

About Stevanato Group

(Free Report)

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

Recommended Stories

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.